• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[硫化砷(As2S2)与STI 571协同诱导K562细胞凋亡]

[Synergism of As2S2 and STI 571 in inducing apoptosis of K562 cells].

作者信息

Li Jun-e, Sun Guan-lin, Wu Ying-li, Wu Wei-li

机构信息

Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2003 Nov;24(11):580-3.

PMID:14720443
Abstract

OBJECTIVE

To investigate the synergistic effect of As(2)S(2) and STI 571 on K562 cells and its mechanism.

METHODS

The inhibitive effect of As(2)S(2) on the proliferation of K562 cells was determined by cell number count. Cell apoptosis was assessed by flow cytometry, DNA fragmentation and morphology. Protein expression was determined by Western-blot and gene expression by RT-PCR.

RESULTS

As(2)S(2) could significantly inhibit the proliferation and induce apoptosis of K562 cells in a dose and time-dependent manner at concentrations from 1 micromol/L to 5 micromol/L for 24 approximately 72 h. 34.4%, 21.8% and 46.0% of the treated-cells displayed apoptosis at 3 micro mol/L for 72 h, 5 micromol/L for 48 h and 5 micromol/L for 72 h, respectively. Compared to treatment with STI571 (0.25 approximately 1.00 micromol/L) or As(2)S(2) (1 approximately 5 micromol/L) alone, treatment of K562 cells with As(2)S(2) and STI571 combination induced more cell apoptosis. (18.4 +/- 1.4)% and (15.8 +/- 1.2)% cells underwent apoptosis at 1 micromol/L STI571 for 48 h and 5 micromol/L As(2)S(2) for 48 h, respectively, and (40.6 +/- 2.0)% cells did in combination treatment (P < 0.05). For U937 cells, the percentages of apoptotic cells were (6.0 +/- 1.1)% at 1 micromol/L STI571 for 48 h, (4.5 +/- 1.2)% at 5 micromol/L As(2)S(2) for 48 h, and (7.3 +/- 1.0)% in combination treatment. As(2)S(2) decreased the bcr-abl fusion protein expression and PTK activity of c-abl and bcr-abl, but not for bcr-abl expression.

CONCLUSION

Combination treatment with As(2)S(2) and STI 571 induced more apoptosis of K562 cells. The reduction of PTK activity may be involved in the mechanisms.

摘要

目的

探讨As₂S₂与STI 571对K562细胞的协同作用及其机制。

方法

通过细胞计数法测定As₂S₂对K562细胞增殖的抑制作用。采用流式细胞术、DNA片段化分析及形态学观察评估细胞凋亡情况。通过蛋白质免疫印迹法检测蛋白质表达,逆转录聚合酶链反应检测基因表达。

结果

在1微摩尔/升至5微摩尔/升浓度下作用24至72小时,As₂S₂能以剂量和时间依赖性方式显著抑制K562细胞增殖并诱导其凋亡。在3微摩尔/升作用72小时、5微摩尔/升作用48小时和5微摩尔/升作用72小时时,分别有34.4%、21.8%和46.0%的处理细胞发生凋亡。与单独使用STI571(0.25至1.00微摩尔/升)或As₂S₂(1至5微摩尔/升)处理相比,As₂S₂与STI571联合处理K562细胞诱导更多细胞凋亡。在1微摩尔/升STI571作用48小时和5微摩尔/升As₂S₂作用48小时时,分别有(18.4±1.4)%和(15.8±1.2)%的细胞发生凋亡,联合处理时有(40.6±2.0)%的细胞发生凋亡(P<0.05)。对于U937细胞,在1微摩尔/升STI571作用48小时时凋亡细胞百分比为(6.0±1.1)%,在5微摩尔/升As₂S₂作用48小时时为(4.5±1.2)%,联合处理时为(7.3±1.0)%。As₂S₂降低了bcr-abl融合蛋白表达以及c-abl和bcr-abl的蛋白酪氨酸激酶(PTK)活性,但对bcr-abl表达无影响。

结论

As₂S₂与STI 571联合处理诱导K562细胞更多凋亡。PTK活性降低可能参与了其机制。

相似文献

1
[Synergism of As2S2 and STI 571 in inducing apoptosis of K562 cells].[硫化砷(As2S2)与STI 571协同诱导K562细胞凋亡]
Zhonghua Xue Ye Xue Za Zhi. 2003 Nov;24(11):580-3.
2
Apoptotic effect of As2S2 on K562 cells and its mechanism.As2S2对K562细胞的凋亡作用及其机制
Acta Pharmacol Sin. 2002 Nov;23(11):991-6.
3
[Preliminary study on the molecular mechanism of K562 cell apoptosis induced by As2S2].[As2S2诱导K562细胞凋亡分子机制的初步研究]
Zhonghua Zhong Liu Za Zhi. 2003 May;25(3):220-4.
4
Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells.伊马替尼(STI571)介导的人类白血病BCR-ABL阳性细胞葡萄糖代谢变化。
Clin Cancer Res. 2004 Oct 1;10(19):6661-8. doi: 10.1158/1078-0432.CCR-04-0039.
5
Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.抑制磷酸酪氨酸磷酸酶1B会使BCR-ABL阳性白血病细胞对ABL激酶抑制剂STI571产生抗性。
Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2025-31. doi: 10.1158/1078-0432.CCR-04-2392.
6
Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells.黄酮哌啶醇增强STI571诱导的BCR-ABL阳性人白血病细胞的线粒体损伤和凋亡。
Clin Cancer Res. 2002 Sep;8(9):2976-84.
7
Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.塞来昔布对K562白血病细胞的抗肿瘤作用是通过细胞周期阻滞、半胱天冬酶-3激活以及Cox-2表达下调介导的,并且与羟基脲或伊马替尼具有协同作用。
Am J Hematol. 2006 Apr;81(4):242-55. doi: 10.1002/ajh.20542.
8
Imatinib (STI571) induces DNA damage in BCR/ABL-expressing leukemic cells but not in normal lymphocytes.伊马替尼(STI571)可诱导表达BCR/ABL的白血病细胞发生DNA损伤,但对正常淋巴细胞无此作用。
Chem Biol Interact. 2005 Apr 15;152(2-3):139-50. doi: 10.1016/j.cbi.2005.03.002.
9
Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells.姜黄素协同增强bcr/abl硫代磷酸酯反义寡核苷酸对慢性粒细胞白血病细胞生长的抑制作用。
Acta Pharmacol Sin. 2007 Jan;28(1):105-10. doi: 10.1111/j.1745-7254.2007.00471.x.
10
Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells.组蛋白去乙酰化酶抑制剂促进STI571介导的对STI571敏感和耐药的Bcr/Abl+人髓系白血病细胞凋亡。
Cancer Res. 2003 May 1;63(9):2118-26.